Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non–small-cell Lung Cancer (NSCLC)

2019 ◽  
Vol 20 (1) ◽  
pp. 43-47 ◽  
Author(s):  
Yasir Y. Elamin ◽  
Daniel R. Gomez ◽  
Mara B. Antonoff ◽  
Jacqulyne P. Robichaux ◽  
Hai Tran ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Tyrosine Kinase ◽  
Small Cell Lung Cancer ◽  
Tyrosine Kinase Inhibitor ◽  
Kinase Inhibitor ◽  
Small Cell ◽  
Consolidation Therapy ◽  
Small Cell Lung ◽  
First Line ◽  
Egfr Mutant

Validation of the digital PCR system in tyrosine kinase inhibitor-resistant EGFR mutant non-small-cell lung cancer

2018 ◽  
Vol 68 (3) ◽  
pp. 167-173 ◽  
Author(s):  
Katsuhiro Masago ◽  
Shiro Fujita ◽  
Akito Hata ◽  
Chiyuki Okuda ◽  
Yuko Yoshizumi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Tyrosine Kinase ◽  
Small Cell Lung Cancer ◽  
Tyrosine Kinase Inhibitor ◽  
Cell Lung Cancer ◽  
Kinase Inhibitor ◽  
Digital Pcr ◽  
Small Cell ◽  
Small Cell Lung ◽  
Egfr Mutant
Sign in / Sign up

Export Citation Format

Share Document